VRG Therapeutics
Onglets principaux
À propos de votre organisation / profil
VRG Therapeutics (VRG Tx) is an original biopharmaceutical R&D company headquartered in Budapest.
VRG Tx leverages its unique drug discovery platform to create cures for diseases through novel mechanisms of action that conventional biopharmaceutical approaches cannot. The VRG Tx platform is verified by our internal pipeline with proven in vivo results in relevant animal models. It can reduce hit validation time to 6 months while reducing preclinical development costs by up to 40%.
VRG Tx’s miniprotein-based portfolio addresses major unmet clinical needs in autoimmune diseases, inflammation, and oncological indications, while also incubating two assets with promising applications, one in migraine prophylaxis (VRG-145) and another one as a CNS medication.
VRG's lead asset is a best-in-class Kv1.3 inhibitor addressing autoimmune diseases (Atopic dermatitis, Psoriasis, IBD) with proven in vivo efficacy.
Réseau (0)
Il n'y a pas encore d'organisations dans le réseau.
Activités récentes
VRG Therapeutics a mis hors ligne une levée de fond levée de fonds.
Le document de type pitchdeck a été mis à jour dans la dataroom.
La dataroom a été mise à jour.
VRG Therapeutics a publié une levée de fonds.
Csikai Tamas a rejoint VRG Therapeutics.